Akero Therapeutics, Inc. (AKRO)
54.65
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
Akero Therapeutics Market Cap: 4.499B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 143.96B |
| Eli Lilly & Co. | 876.65B |
| Bristol Myers Squibb Co. | 102.79B |
| Adaptive Biotechnologies Corp. | 2.317B |
| Johnson & Johnson | 484.75B |
Market Cap Related Metrics
| PEG Ratio | -227.56 |
| Price to Book Value | 4.698 |
| Price | 54.65 |
| Earnings Yield | -6.86% |
| PEGY Ratio | -227.56 |